menu
    • menu

    Company profile for SQ Innovation

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SQ Innovation is a privately held Swiss biopharmaceutical company with locations in Zug, Switzerland, and Burlington, Massachusetts, USA. Founded to revolutionize patient care, we develop and commercialize innovative, cost-effective therapies for subcutaneous delivery, enabling at-home treatment for conditions traditionally managed in hospitals. At SQ Innovation, we are committed to advancing healthcare solutions that improve ...
    SQ Innovation is a privately held Swiss biopharmaceutical company with locations in Zug, Switzerland, and Burlington, Massachusetts, USA. Founded to revolutionize patient care, we develop and commercialize innovative, cost-effective therapies for subcutaneous delivery, enabling at-home treatment for conditions traditionally managed in hospitals. At SQ Innovation, we are committed to advancing healthcare solutions that improve patient outcomes, enhance accessibility, and reduce the burden on healthcare systems.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SQ InnovationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20 Burlington Mall Road, Suite 220 Burlington, MA 01803
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sqinnovation.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SQ Innovation Launches Lasix® ONYU With U.S. Pharma Distributors
    SQ Innovation Launches Lasix® ONYU With U.S. Pharma Distributors

    09 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sq-innovations-lasix-onyu-now-available-for-order-through-major-us-pharmaceutical-distributors-302682200.html

    PR NEWSWIRE
    09 Feb 2026
    Share Share
    Ligand Partners With SQ Innovation For FDA Approval Of lasix Onyu
    Ligand Partners With SQ Innovation For FDA Approval Of lasix Onyu

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3164011/0/en/Ligand-Partner-SQ-Innovation-Receives-FDA-Approval-for-Lasix-ONYU-an-At-Home-Treatment-for-Edema-in-Heart-Failure-Patients.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    SQ Innovation Launches Fda-Approved Lasix® ONYU For Heart Failure
    SQ Innovation Launches Fda-Approved Lasix® ONYU For Heart Failure

    08 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sq-innovation-announces-fda-approval-of-lasix-onyu-for-treatment-of-edema-in-heart-failure-302578015.html

    PR NEWSWIRE
    08 Oct 2025
    Share Share
    SQ Innovation’s Lasix Onyu Receives Approval In US
    SQ Innovation’s Lasix Onyu Receives Approval In US

    07 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217294

    FDA
    07 Oct 2025
    Share Share
    Gerresheimer: FDA Grants Tentative Approval for SQ Innovation's Lasix ONYU
    Gerresheimer: FDA Grants Tentative Approval for SQ Innovation's Lasix ONYU

    16 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gerresheimer-fda-grants-tentative-approval-of-sq-innovations-lasix-onyu-302332406.html

    PR NEWSWIRE
    16 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search